What is the current BRN.AX stock price and volume?

BRN.AX stock is trading at **A$0.155** pre-market (03 Feb 2026). Yesterday’s volume was **10,813,680**, above the average volume of **8,473,980**, signalling higher intraday interest.

What price target and forecast exist for BRN.AX stock?

Meyka AI's forecast model projects a yearly price of **A$0.1904**, implying **22.83%** upside from **A$0.155**. Short-term targets used by analysts include **A$0.11** (conservative) and **A$0.21** (optimistic). Forecasts are model-based projections and not guarantees.

How does the Meyka AI grade affect BRN.AX stock view?

Meyka AI rates BRN.AX **64.90/100 (Grade B, HOLD)**. The grade blends benchmark, sector, financial growth, metrics and analyst inputs. It is an informational tool and not personalised financial advice.

What are the main risks for BRN.AX stock investors?

Key risks for BRN.AX stock are continued operating losses, high valuation multiples, concentrated institutional coverage, and product adoption timing. A weaker-than-expected earnings report on 04 Mar 2026 could exacerbate downside.

AU Stocks

BRN.AX BrainChip (ASX) A$0.155 pre-market 03 Feb 2026: earnings on 04 Mar

ByHuzaifa Zahoor February 3, 2026

BRN.AX stock is trading at A$0.155 pre-market on 03 Feb 2026 with 10,813,680 shares changing hands yesterday. We see the imminent earnings announcement on 04 Mar 2026 as the main near-term catalyst for BrainChip Holdings Ltd (BRN.AX) on the ASX. Volume is elevated versus the 50-day average, and the company’s Akida neuromorphic chips keep BrainChip in the AI stocks conversation. Meyka AI provides this data-driven market view to frame risks and upside ahead of the report.